{"protocolSection": {"identificationModule": {"nctId": "NCT03016325", "orgStudyIdInfo": {"id": "CV013-011"}, "secondaryIdInfos": [{"id": "2016-001685-29", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Bristol-Myers Squibb", "class": "INDUSTRY"}, "briefTitle": "Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure", "officialTitle": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients With Heart Failure and Impaired Systolic Function", "acronym": "STANDUP AHF"}, "statusModule": {"statusVerifiedDate": "2020-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-01-13", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-06-23", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-11-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-01-09", "studyFirstSubmitQcDate": "2017-01-09", "studyFirstPostDateStruct": {"date": "2017-01-10", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-06-22", "resultsFirstSubmitQcDate": "2020-08-07", "resultsFirstPostDateStruct": {"date": "2020-08-19", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-12-11", "lastUpdatePostDateStruct": {"date": "2021-01-06", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Bristol-Myers Squibb", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "A Study to Evaluate Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of HNO Donor in Hospitalized Patients with Heart Failure and Impaired Systolic Function"}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 329, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Part 1 Cohort 1 HNO Donor", "type": "EXPERIMENTAL", "interventionNames": ["Drug: HNO Donor"]}, {"label": "Placebo Part 1 Cohort 1", "type": "PLACEBO_COMPARATOR", "interventionNames": ["Drug: Placebo"]}, {"label": "Part 2 Cohort 2 HNO Donor- low dose", "type": "EXPERIMENTAL", "interventionNames": ["Drug: HNO Donor"]}, {"label": "Part 2 Cohort 2 HNO Donor- high dose", "type": "EXPERIMENTAL", "interventionNames": ["Drug: HNO Donor"]}, {"label": "Placebo Part 2 Cohort 2", "type": "PLACEBO_COMPARATOR", "interventionNames": ["Drug: Placebo"]}], "interventions": [{"type": "DRUG", "name": "HNO Donor", "description": "Infusion", "armGroupLabels": ["Part 1 Cohort 1 HNO Donor", "Part 2 Cohort 2 HNO Donor- high dose", "Part 2 Cohort 2 HNO Donor- low dose"], "otherNames": ["BMS-986231"]}, {"type": "DRUG", "name": "Placebo", "description": "Infusion", "armGroupLabels": ["Placebo Part 1 Cohort 1", "Placebo Part 2 Cohort 2"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Percentage of Participants With Clinically Relevant Hypotension up to 6 Hours After the End of Study Drug Infusion", "description": "Percentage of participants with clinically relevant hypotension, defined by systolic blood pressure (SBP) \\< 90 mm Hg (confirmed by a repeated value \\< 90 mm Hg) or symptoms of hypotension, up to 6 hours after the end of study drug infusion", "timeFrame": "From start of infusion up to 6 hours post end of infusion"}], "secondaryOutcomes": [{"measure": "Change in NT-proBNP From Baseline to Hour 24, 48, 72, 120 or Discharge (Whichever Comes First), and at Day 32", "description": "Assess the effect of BMS-986231 on NT-proBNP (N-terminal prohormone of brain natriuretic peptide)", "timeFrame": "0, 24, 48, 72, 120 hour or discharge; Day 32"}, {"measure": "Change in Participant-reported Resting Dyspnea From Baseline Through Hour 72", "description": "Endpoint was measured by the area under the curve (AUC) of the 11-point Numerical Rating Scale (NRS) obtained at baseline, and Hours 6, 12, 24, 48, and 72.\n\nParticipants were asked to report their absolute current severity of dyspnea on an 11-point numerical rating scale (NRS; range 0 to 10).\n\nThe numerical rating scale (NRS) was used to assess the degree of dyspnea (breathlessness), measured using an 11-point scale provided by the Sponsor.\n\nA score of 0 represents \"I am not breathless at all\" and 10 represents \"I am the most breathless I can possibly imagine\".", "timeFrame": "Hours 6, 12, 24, 48, and 72"}, {"measure": "Percentage of Participants With Symptomatic Hypotension up to 6 Hours After the End of Study Drug Infusion", "description": "The percentage of participants experiencing symptoms of hypotension up to 6 hours post-treatment was reported for each arm.", "timeFrame": "From start of infusion up to 6 hours post end of infusion"}, {"measure": "Percentage of Participants With SBP < 90 mm Hg (Confirmed by a Repeated Value)", "description": "The percentage of participants experiencing SBP \\< 90 mm Hg (confirmed by a repeated value) up to 6 hours post-treatment was reported for each arm.", "timeFrame": "From start of infusion up to 6 hours post end of infusion"}, {"measure": "Number of Participants With a Serious Adverse Events (SAE) Assessed up to Day 32", "description": "Number of participants who experienced an in-study SAE.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0 Included serious adverse events with onset time from the start of study treatment, up to and including 32 days after the start of study treatment.", "timeFrame": "32 days"}, {"measure": "Number of Participants Who Discontinued Due to Hypotension", "description": "Number of participants who discontinued study treatment due to hypotension.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nIncluded nonserious adverse events with onset time from the start of study treatment, up to and including 120 hours after the start of study treatment and serious adverse events with onset time from the start of study treatment, up to and including 32 days after the start of study treatment.\n\nHypotension defined as systolic blood pressure (SBP) \\< 90 mmHg.", "timeFrame": "up to 120 hours (for AEs); up to 32 days (for SAEs)"}, {"measure": "Number of Participants Who Discontinued, Experienced a Down-titration or Dose Interruption Due to Decreased Blood Pressure", "description": "Number of participants who discontinued study treatment, experienced a down-titration (dose reduction) or dose interruption due to decreased blood pressure/hypotension are reported below.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nIncluded nonserious adverse events with onset time from the start of study treatment, up to and including 120 hours after the start of study treatment and serious adverse events with onset time from the start of study treatment, up to and including 32 days after the start of study treatment.\n\nIf the participant experienced systolic blood pressure (SBP) \\< 95 mm Hg, without symptoms related to hypotension, the measurement was repeated within 15 minutes. If the SBP remained \\< 95 mm Hg, the dose reduction occurred.", "timeFrame": "up to 120 hours (for AEs); up to 32 days (for SAEs)"}, {"measure": "Number of Participants With an Adverse Event (AE) Assessed up to 120 Hours", "description": "Number of participants who experienced an in-study AE.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nIncluded nonserious adverse events with onset time from the start of study treatment, up to and including 120 hours after the start of study treatment.", "timeFrame": "up to 120 hours"}, {"measure": "Number of Participants Who Died (All- Cause and Cardiovascular-related) Through Day 182", "description": "Number of participants who died (all- cause and CV related) through Day 182.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nCV=Cardiovascular", "timeFrame": "through 182 days"}, {"measure": "Change in Troponin T From Baseline to Hour 24, 48, and 72", "description": "Baseline = Last non-missing result with a collection date-time less than or on the date-time of the start of infusion of study drug", "timeFrame": "from baseline to Hour 24, 48, and 72"}, {"measure": "Number of Participants With Marked Laboratory Abnormality Assessed to 120 Hours - Hematology", "description": "Number of participants who experienced an in-study Hematology marked laboratory abnormality (reported in \\> 5% of total participants).\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0", "timeFrame": "to 120 hours"}, {"measure": "Number of Participants With Marked Laboratory Abnormality Assessed to 120 Hours - Chemistry", "description": "Number of participants who experienced an in-study Chemistry marked laboratory abnormality (reported in \\> 5% of total participants).\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0", "timeFrame": "to 120 hours"}, {"measure": "Number of Participants With Marked Laboratory Abnormality Assessed to 120 Hours - Urinalysis", "description": "Number of participants who experienced an in-study Urinalysis marked laboratory abnormality (reported in \\> 5% of total participants).\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0", "timeFrame": "to 120 hours"}, {"measure": "Change in Vital Signs From Baseline to 120 Hours - Blood Pressure", "description": "The change in baseline for vital signs was reported for each arm.", "timeFrame": "to 120 hours"}, {"measure": "Change in Vital Signs From Baseline to 120 Hours - Heart Rate", "description": "The change in baseline for vital signs was reported for each arm.", "timeFrame": "to 120 hours"}, {"measure": "Change in Vital Signs From Baseline to 120 Hours - Respiratory Rate", "description": "The change in baseline for vital signs was reported for each arm.", "timeFrame": "to 120 hours"}, {"measure": "Change in Vital Signs From Baseline to 120 Hours - Temperature", "description": "The change in baseline for vital signs was reported for each arm.", "timeFrame": "to 120 hours"}, {"measure": "Change in Electrocardiograms (ECGs) From Baseline to 120 Hours - Mean Heart Rate", "description": "The change in baseline for ECGs was reported for each arm.", "timeFrame": "to 120 hours"}, {"measure": "Change in Electrocardiograms (ECGs) From Baseline to 120 Hours - PR, QT, QTcF Intervals and QRS Duration", "description": "The change in baseline for ECGs was reported for each arm.", "timeFrame": "to 120 hours"}, {"measure": "Change in Physical Measurements From Baseline to 120 Hours", "description": "The change in baseline for physical measurements was reported for each arm.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - x10^9 Cells/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - g/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - mmol/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - U/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - mg/dL", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - x10^12 c/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Protein (Nmol/L)", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Creatinine (\u00b5mol/L)", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Cystatin (mg/L)", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Percentage Fractional Potassium Excretion", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "timeFrame": "to 120 hours"}, {"measure": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Percentage Fractional Sodium Excretion", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "timeFrame": "to 120 hours"}]}, "eligibilityModule": {"eligibilityCriteria": "For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com\n\nInclusion Criteria:\n\n* Actively being hospitalized for acute decompensated heart failure\n* At least 1 administration of IV diuretic for the current episode\n* Be randomized within 18 hours of first dose of IV diuretic for current episode for Part 1 Cohort 1, or 48 hours for first dose for Part II Cohort II\n* Have shortness of breath at rest or with minimal exertion after administration of 1 dose of IV diuretic\n* Have history of heart failure and a left ventricular ejection fraction (LVEF) \u2264 40%\n\nExclusion Criteria:\n\n* Systolic blood pressure \\<105mm Hg or \\>160mm Hg or heart rate \\<50 or \\>130 bpm\n* Have an active infection requiring IV anti-microbial treatment\n* Be hospitalized with acute coronary syndrome, coronary revascularization or acute myocardial infarction during the previous 90 days prior to screening\n* Have a history of a cerebral vascular accident (CVA or stroke) or of a transient ischemic attack (TIA) during the previous 90 days prior to screening\n* Suspected acute lung disease (e.g pneumonia or asthma) or severe chronic lung disease (e.g. severe chronic obstructive pulmonary disease, or pulmonary fibrosis)\n\nOther protocol defined inclusion/exclusion criteria could apply", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Bristol-Myers Squibb", "affiliation": "Bristol-Myers Squibb", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "University of Arizona Sarver Heart Center", "city": "Tucson", "state": "Arizona", "zip": "85724", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"facility": "University of Florida", "city": "Gainesville", "state": "Florida", "zip": "32610", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"facility": "Tampa General Hospital", "city": "Tampa", "state": "Florida", "zip": "33606", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Emory University", "city": "Atlanta", "state": "Georgia", "zip": "30322", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Indiana University Health Methodist Hospital", "city": "Indianapolis", "state": "Indiana", "zip": "46202", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "University of Maryland Medical Center", "city": "Baltimore", "state": "Maryland", "zip": "21201", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "DMC Detroit Receiving Hospital", "city": "Detroit", "state": "Michigan", "zip": "48201", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Harper University Hospital", "city": "Detroit", "state": "Michigan", "zip": "48201", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Henry Ford Health System", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Sinai Grace Hospital", "city": "Detroit", "state": "Michigan", "zip": "48235", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Saint Louis University", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "Washington University", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "University of North Carolina at Chapel Hill", "city": "Chapel Hill", "state": "North Carolina", "zip": "27599", "country": "United States", "geoPoint": {"lat": 35.9132, "lon": -79.05584}}, {"facility": "Duke University Medical Center", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "University of Cincinnati", "city": "Cincinnati", "state": "Ohio", "zip": "45267", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "Wexner Medical Center at The Ohio State University", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "University of Pennsylvania", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19104", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Thomas Jefferson University", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19107", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Medical University of South Carolina - PPDS", "city": "Charleston", "state": "South Carolina", "zip": "29425", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "Vanderbilt University Medical Center", "city": "Nashville", "state": "Tennessee", "zip": "37232", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "University of Texas Southwestern Medical Center", "city": "Dallas", "state": "Texas", "zip": "75390", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Ben Taub General Hospital", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "University of Utah Medical Center", "city": "Salt Lake City", "state": "Utah", "zip": "84132", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "University of Virginia Health System", "city": "Charlottesville", "state": "Virginia", "zip": "22908", "country": "United States", "geoPoint": {"lat": 38.02931, "lon": -78.47668}}, {"facility": "Local Institution", "city": "Caba", "state": "Buenos Aires", "zip": "C1428ART", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Local Institution", "city": "Rosario", "state": "Santa FE", "zip": "Santa Fe, 2000", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Local Institution", "city": "Buenos Aires", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Local Institution", "city": "Cordoba", "zip": "5000", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Local Institution", "city": "Cordoba", "zip": "X5000AAX", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Local Institution", "city": "Cordoba", "zip": "X5000EPU", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Local Institution", "city": "Cordoba", "zip": "X5000JHQ", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Local Institution", "city": "Cordoba", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Local Institution", "city": "Corrientes", "zip": "3400", "country": "Argentina", "geoPoint": {"lat": -27.4806, "lon": -58.8341}}, {"facility": "Local Institution", "city": "Santa Fe", "zip": "3000", "country": "Argentina", "geoPoint": {"lat": -31.63333, "lon": -60.7}}, {"facility": "Local Institution", "city": "Edmonton", "state": "Alberta", "zip": "T6G 2R3", "country": "Canada", "geoPoint": {"lat": 53.55014, "lon": -113.46871}}, {"facility": "Local Institution", "city": "Halifax", "state": "Nova Scotia", "zip": "B3H 4S9", "country": "Canada", "geoPoint": {"lat": 44.64533, "lon": -63.57239}}, {"facility": "Local Institution", "city": "Quebec", "zip": "G1V 4G5", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"facility": "Local Institution", "city": "Brno", "zip": "625 00", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "Local Institution", "city": "Brno", "zip": "656 91", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "Local Institution", "city": "Hradec Kralove", "zip": "500 05", "country": "Czechia", "geoPoint": {"lat": 50.20923, "lon": 15.83277}}, {"facility": "Local Institution", "city": "Plzen-Bory", "zip": "305 99", "country": "Czechia", "geoPoint": {"lat": 49.74747, "lon": 13.37759}}, {"facility": "Local Institution", "city": "Prague", "zip": "12808", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Local Institution", "city": "Praha 4", "zip": "140 21", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Local Institution", "city": "Slany", "zip": "274 01", "country": "Czechia", "geoPoint": {"lat": 50.23046, "lon": 14.08693}}, {"facility": "Local Institution", "city": "Besancon", "zip": "25000", "country": "France", "geoPoint": {"lat": 47.24878, "lon": 6.01815}}, {"facility": "Local Institution", "city": "Beziers", "zip": "34500", "country": "France", "geoPoint": {"lat": 43.34122, "lon": 3.21402}}, {"facility": "Local Institution", "city": "Bobigny", "zip": "93009", "country": "France", "geoPoint": {"lat": 48.9, "lon": 2.45}}, {"facility": "Local Institution", "city": "Creteil", "country": "France", "geoPoint": {"lat": 48.78333, "lon": 2.46667}}, {"facility": "Local Institution", "city": "Evreux", "zip": "27015", "country": "France", "geoPoint": {"lat": 49.02414, "lon": 1.15082}}, {"facility": "Local Institution", "city": "La Tronche", "zip": "38700", "country": "France", "geoPoint": {"lat": 45.20429, "lon": 5.73645}}, {"facility": "Local Institution", "city": "Paris Cedex 10", "zip": "75475", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"facility": "Local Institution", "city": "Paris", "zip": "75013", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"facility": "Local Institution", "city": "Bad Nauheim", "zip": "61231", "country": "Germany", "geoPoint": {"lat": 50.36463, "lon": 8.73859}}, {"facility": "Local Institution", "city": "Frankfurt", "zip": "60590", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Local Institution", "city": "Gottingen", "zip": "37075", "country": "Germany", "geoPoint": {"lat": 51.53443, "lon": 9.93228}}, {"facility": "Local Institution", "city": "Greifswald", "country": "Germany", "geoPoint": {"lat": 54.09311, "lon": 13.38786}}, {"facility": "Local Institution", "city": "Hamburg", "zip": "20246", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Local Institution", "city": "Hannover", "zip": "30625", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"facility": "Local Institution", "city": "Homburg", "zip": "66421", "country": "Germany", "geoPoint": {"lat": 49.32637, "lon": 7.33867}}, {"facility": "Local Institution", "city": "Ludwigshafen", "zip": "67063", "country": "Germany", "geoPoint": {"lat": 49.48121, "lon": 8.44641}}, {"facility": "Local Institution", "city": "Mainz", "country": "Germany", "geoPoint": {"lat": 49.98419, "lon": 8.2791}}, {"facility": "Local Institution", "city": "Regensburg", "zip": "935053", "country": "Germany", "geoPoint": {"lat": 49.01513, "lon": 12.10161}}, {"facility": "Local Institution", "city": "Athens, Attiki", "zip": "11527", "country": "Greece"}, {"facility": "Local Institution", "city": "Athens", "zip": "11527", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Local Institution", "city": "Athens", "zip": "12464", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Local Institution", "city": "Athens", "zip": "14233", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Local Institution", "city": "Ioannina", "zip": "45500", "country": "Greece", "geoPoint": {"lat": 39.66486, "lon": 20.85189}}, {"facility": "Local Institution", "city": "Kallithea", "zip": "17674", "country": "Greece", "geoPoint": {"lat": 37.95, "lon": 23.7}}, {"facility": "Local Institution", "city": "Larisa", "zip": "41110", "country": "Greece", "geoPoint": {"lat": 39.63689, "lon": 22.41761}}, {"facility": "Local Institution", "city": "Thessaloniki", "zip": "54636", "country": "Greece", "geoPoint": {"lat": 40.64361, "lon": 22.93086}}, {"facility": "Local Institution", "city": "Brescia", "zip": "25123", "country": "Italy", "geoPoint": {"lat": 45.53558, "lon": 10.21472}}, {"facility": "Local Institution", "city": "Ferrara", "zip": "44121", "country": "Italy", "geoPoint": {"lat": 44.83804, "lon": 11.62057}}, {"facility": "Local Institution", "city": "Foggia", "zip": "71121", "country": "Italy", "geoPoint": {"lat": 41.45845, "lon": 15.55188}}, {"facility": "Local Institution", "city": "Nagoya-shi", "state": "Aichi", "zip": "4678602", "country": "Japan", "geoPoint": {"lat": 35.18147, "lon": 136.90641}}, {"facility": "Local Institution", "city": "Seto", "state": "Aichi", "zip": "489-0065", "country": "Japan", "geoPoint": {"lat": 35.23333, "lon": 137.1}}, {"facility": "Local Institution", "city": "Fukushima-shi", "state": "Fukushima", "zip": "9601295", "country": "Japan", "geoPoint": {"lat": 37.75, "lon": 140.46667}}, {"facility": "Local Institution", "city": "Sapporo-shi", "state": "Hokkaido", "zip": "0608648", "country": "Japan", "geoPoint": {"lat": 43.06667, "lon": 141.35}}, {"facility": "Local Institution", "city": "Amagasaki", "state": "Hyogo", "zip": "6608550", "country": "Japan", "geoPoint": {"lat": 34.71667, "lon": 135.41667}}, {"facility": "Local Institution", "city": "Sagamihara-shi", "state": "Kanagawa", "zip": "2520375", "country": "Japan", "geoPoint": {"lat": 35.54899, "lon": 139.26064}}, {"facility": "Local Institution", "city": "Yokohama", "state": "Kanagawa", "zip": "227-8501", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Local Institution", "city": "Yokohama", "state": "Kanagawa", "zip": "232-0024", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Local Institution", "city": "Okayama-shi", "state": "Okayama", "zip": "7008558", "country": "Japan", "geoPoint": {"lat": 34.65, "lon": 133.93333}}, {"facility": "Local Institution", "city": "Suita-shi", "state": "Osaka", "country": "Japan", "geoPoint": {"lat": 34.76143, "lon": 135.51567}}, {"facility": "Local Institution", "city": "Kawaguchi", "state": "Saitama", "zip": "333-0842", "country": "Japan", "geoPoint": {"lat": 35.80521, "lon": 139.71072}}, {"facility": "Local Institution", "city": "Bunkyo-ku", "state": "Tokyo", "zip": "1138431", "country": "Japan", "geoPoint": {"lat": 35.37517, "lon": 139.92991}}, {"facility": "Local Institution", "city": "Bunkyo-ku", "state": "Tokyo", "zip": "1138603", "country": "Japan", "geoPoint": {"lat": 35.37517, "lon": 139.92991}}, {"facility": "Local Institution", "city": "Itabashi-ku", "state": "Tokyo", "zip": "1738610", "country": "Japan", "geoPoint": {"lat": 35.74893, "lon": 139.71497}}, {"facility": "Local Institution", "city": "Osaka", "zip": "558-8558", "country": "Japan", "geoPoint": {"lat": 34.69374, "lon": 135.50218}}, {"facility": "Local Institution", "city": "Tokyo", "zip": "113-8655", "country": "Japan", "geoPoint": {"lat": 35.6895, "lon": 139.69171}}, {"facility": "Local Institution", "city": "Tokyo", "zip": "162-8655", "country": "Japan", "geoPoint": {"lat": 35.6895, "lon": 139.69171}}, {"facility": "Local Institution", "city": "Amersfoort", "zip": "3818 ES", "country": "Netherlands", "geoPoint": {"lat": 52.155, "lon": 5.3875}}, {"facility": "Local Institution", "city": "Deventer", "zip": "7416 SE", "country": "Netherlands", "geoPoint": {"lat": 52.255, "lon": 6.16389}}, {"facility": "Local Institution", "city": "Hardenberg", "zip": "7772 SE", "country": "Netherlands", "geoPoint": {"lat": 52.57583, "lon": 6.61944}}, {"facility": "Local Institution", "city": "Leeuwarden", "zip": "8934 AD", "country": "Netherlands", "geoPoint": {"lat": 53.20139, "lon": 5.80859}}, {"facility": "Local Institution", "city": "Bialystok", "zip": "15-276", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Local Institution", "city": "Katowice", "zip": "40-635", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"facility": "Local Institution", "city": "Krakow", "zip": "31-202", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Local Institution", "city": "Lodz", "zip": "91-347", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Local Institution", "city": "Lodz", "zip": "92-213", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Local Institution", "city": "Warszawa", "zip": "04-628", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "Local Institution", "city": "Wroclaw", "zip": "50-981", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "Local Institution", "city": "Wroclaw", "zip": "54-049", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "Local Institution", "city": "Zamosc", "zip": "22-400", "country": "Poland", "geoPoint": {"lat": 50.72314, "lon": 23.25196}}, {"facility": "Local Institution", "city": "Alicante", "zip": "03010", "country": "Spain", "geoPoint": {"lat": 38.34517, "lon": -0.48149}}, {"facility": "Local Institution", "city": "Barcelona", "zip": "08025", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Local Institution", "city": "Barcelona", "zip": "8035", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Local Institution", "city": "L'Hospitalet de Llobregat", "zip": "08907", "country": "Spain", "geoPoint": {"lat": 41.35967, "lon": 2.10028}}, {"facility": "Local Institution", "city": "Madrid", "zip": "28007", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Local Institution", "city": "Madrid", "zip": "28041", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Local Institution", "city": "Sant Joan Despi", "zip": "08970", "country": "Spain", "geoPoint": {"lat": 41.36718, "lon": 2.0574}}, {"facility": "Local Institution", "city": "Santiago De Compostela", "zip": "15706", "country": "Spain", "geoPoint": {"lat": 42.88052, "lon": -8.54569}}, {"facility": "Local Institution", "city": "Belfast", "zip": "BT16 1RH", "country": "United Kingdom", "geoPoint": {"lat": 54.59682, "lon": -5.92541}}, {"facility": "Local Institution", "city": "Blackpool", "zip": "FY3 8NR", "country": "United Kingdom", "geoPoint": {"lat": 53.81667, "lon": -3.05}}, {"facility": "Local Institution", "city": "Glasgow", "zip": "G4 0SF", "country": "United Kingdom", "geoPoint": {"lat": 55.86515, "lon": -4.25763}}, {"facility": "Local Institution", "city": "Glasgow", "zip": "G51 4TF", "country": "United Kingdom", "geoPoint": {"lat": 55.86515, "lon": -4.25763}}, {"facility": "Local Institution", "city": "London", "zip": "SW17 0QT", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}]}, "referencesModule": {"references": [{"pmid": "33248986", "type": "DERIVED", "citation": "Felker GM, McMurray JJV, Cleland JG, O'Connor CM, Teerlink JR, Voors AA, Belohlavek J, Bohm M, Borentain M, Bueno H, Cole RT, DeSouza MM, Ezekowitz JA, Filippatos G, Lang NN, Kessler PD, Martinez FA, Mebazaa A, Metra M, Mosterd A, Pang PS, Ponikowski P, Sato N, Seiffert D, Ye J. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study. JACC Heart Fail. 2021 Feb;9(2):146-157. doi: 10.1016/j.jchf.2020.10.012. Epub 2020 Nov 25."}, {"pmid": "30703258", "type": "DERIVED", "citation": "Cowart D, Venuti RP, Lynch K, Guptill JT, Noveck RJ, Foo SY. A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers. J Clin Pharmacol. 2019 May;59(5):717-730. doi: 10.1002/jcph.1364. Epub 2019 Jan 31."}], "seeAlsoLinks": [{"label": "BMS Clinical Trial Information", "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"}, {"label": "BMS Clinical Trial Patient Recruiting", "url": "https://www.bmsstudyconnect.com/s/US/English/USenHome"}, {"label": "FDA Safety Alerts and Recalls", "url": "https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Main study cohorts: 100 participants in Part I and 222 in Part II were assigned to treatment (322 randomized in total), of which 97 and 214, respectively, were treated (311 total treated). Reasons not treated (Part I): 3 other reasons. Reasons not treated (Part II): 2 no longer met study criteria; 1 adverse event (AE); 5 other reasons.\n\nJapanese-specific cohort: 18 participants were randomized and treated in Part II (Japan cohort)", "groups": [{"id": "FG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "FG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "FG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "FG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "FG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "FG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "FG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "FG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "periods": [{"title": "Treatment Period", "milestones": [{"type": "STARTED", "comment": "Started = Entering treatment period", "achievements": [{"groupId": "FG000", "numSubjects": "48"}, {"groupId": "FG001", "numSubjects": "49"}, {"groupId": "FG002", "numSubjects": "71"}, {"groupId": "FG003", "numSubjects": "71"}, {"groupId": "FG004", "numSubjects": "72"}, {"groupId": "FG005", "numSubjects": "6"}, {"groupId": "FG006", "numSubjects": "6"}, {"groupId": "FG007", "numSubjects": "6"}]}, {"type": "COMPLETED", "comment": "Completed = Finished 120 hour treatment period", "achievements": [{"groupId": "FG000", "numSubjects": "48"}, {"groupId": "FG001", "numSubjects": "48"}, {"groupId": "FG002", "numSubjects": "70"}, {"groupId": "FG003", "numSubjects": "71"}, {"groupId": "FG004", "numSubjects": "70"}, {"groupId": "FG005", "numSubjects": "6"}, {"groupId": "FG006", "numSubjects": "6"}, {"groupId": "FG007", "numSubjects": "6"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Participant withdrew consent", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Participant refuses assessments", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}]}, {"title": "32-Day Follow-Up Period", "milestones": [{"type": "STARTED", "comment": "Started = Entering treatment period", "achievements": [{"groupId": "FG000", "numSubjects": "48"}, {"groupId": "FG001", "numSubjects": "49"}, {"groupId": "FG002", "numSubjects": "71"}, {"groupId": "FG003", "numSubjects": "71"}, {"groupId": "FG004", "numSubjects": "72"}, {"groupId": "FG005", "numSubjects": "6"}, {"groupId": "FG006", "numSubjects": "6"}, {"groupId": "FG007", "numSubjects": "6"}]}, {"type": "COMPLETED", "comment": "Completed = Finished 32-day follow-up period", "achievements": [{"groupId": "FG000", "numSubjects": "44"}, {"groupId": "FG001", "numSubjects": "47"}, {"groupId": "FG002", "numSubjects": "62"}, {"groupId": "FG003", "numSubjects": "63"}, {"groupId": "FG004", "numSubjects": "64"}, {"groupId": "FG005", "numSubjects": "6"}, {"groupId": "FG006", "numSubjects": "5"}, {"groupId": "FG007", "numSubjects": "6"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "9"}, {"groupId": "FG003", "numSubjects": "8"}, {"groupId": "FG004", "numSubjects": "8"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "1"}, {"groupId": "FG007", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "5"}, {"groupId": "FG003", "numSubjects": "6"}, {"groupId": "FG004", "numSubjects": "3"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Poor/non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Participant refused to visit", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Participant withdrew consent", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "1"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Family doctor OK'd participant, per call", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "withdrew from Day 5, D32 form not done", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}]}, {"title": "182-Day Follow-Up Period", "milestones": [{"type": "STARTED", "comment": "Started = Entering treatment period", "achievements": [{"groupId": "FG000", "numSubjects": "48"}, {"groupId": "FG001", "numSubjects": "49"}, {"groupId": "FG002", "numSubjects": "71"}, {"groupId": "FG003", "numSubjects": "71"}, {"groupId": "FG004", "numSubjects": "72"}, {"groupId": "FG005", "numSubjects": "6"}, {"groupId": "FG006", "numSubjects": "6"}, {"groupId": "FG007", "numSubjects": "6"}]}, {"type": "COMPLETED", "comment": "Completed = Finished 182-day follow-up period", "achievements": [{"groupId": "FG000", "numSubjects": "44"}, {"groupId": "FG001", "numSubjects": "45"}, {"groupId": "FG002", "numSubjects": "60"}, {"groupId": "FG003", "numSubjects": "58"}, {"groupId": "FG004", "numSubjects": "60"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "2"}, {"groupId": "FG007", "numSubjects": "1"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "11"}, {"groupId": "FG003", "numSubjects": "13"}, {"groupId": "FG004", "numSubjects": "12"}, {"groupId": "FG005", "numSubjects": "5"}, {"groupId": "FG006", "numSubjects": "4"}, {"groupId": "FG007", "numSubjects": "5"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "11"}, {"groupId": "FG003", "numSubjects": "12"}, {"groupId": "FG004", "numSubjects": "9"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "1"}]}, {"type": "Alive, per national insurance system", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Participant withdrew consent", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "1"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Alive, per Family doctor", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Alive, per civil unit", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Vital status collected via EMR", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "withdrew from D5, D32/182 forms not done", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "No cont D182 FU, Sponsor admin reason", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "5"}, {"groupId": "FG006", "numSubjects": "3"}, {"groupId": "FG007", "numSubjects": "4"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "BG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "BG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "BG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "BG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "BG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "BG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "BG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "BG008", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "48"}, {"groupId": "BG001", "value": "49"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "72"}, {"groupId": "BG005", "value": "6"}, {"groupId": "BG006", "value": "6"}, {"groupId": "BG007", "value": "6"}, {"groupId": "BG008", "value": "329"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "66.0", "spread": "12.23"}, {"groupId": "BG001", "value": "64.6", "spread": "12.23"}, {"groupId": "BG002", "value": "67.3", "spread": "11.52"}, {"groupId": "BG003", "value": "69.2", "spread": "11.41"}, {"groupId": "BG004", "value": "70.0", "spread": "11.52"}, {"groupId": "BG005", "value": "65.3", "spread": "17.88"}, {"groupId": "BG006", "value": "69.5", "spread": "13.31"}, {"groupId": "BG007", "value": "76.7", "spread": "10.48"}, {"groupId": "BG008", "value": "67.9", "spread": "11.94"}]}]}]}, {"title": "Age, Customized", "description": "Age categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "< 65 years", "measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "24"}, {"groupId": "BG002", "value": "21"}, {"groupId": "BG003", "value": "23"}, {"groupId": "BG004", "value": "19"}, {"groupId": "BG005", "value": "3"}, {"groupId": "BG006", "value": "3"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "111"}]}, {"title": "65 -to <=75 years", "measurements": [{"groupId": "BG000", "value": "22"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "36"}, {"groupId": "BG003", "value": "26"}, {"groupId": "BG004", "value": "30"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "2"}, {"groupId": "BG008", "value": "132"}]}, {"title": ">75 years", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "14"}, {"groupId": "BG003", "value": "22"}, {"groupId": "BG004", "value": "23"}, {"groupId": "BG005", "value": "3"}, {"groupId": "BG006", "value": "2"}, {"groupId": "BG007", "value": "3"}, {"groupId": "BG008", "value": "86"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "20"}, {"groupId": "BG004", "value": "15"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "2"}, {"groupId": "BG008", "value": "74"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "40"}, {"groupId": "BG001", "value": "39"}, {"groupId": "BG002", "value": "53"}, {"groupId": "BG003", "value": "51"}, {"groupId": "BG004", "value": "57"}, {"groupId": "BG005", "value": "6"}, {"groupId": "BG006", "value": "5"}, {"groupId": "BG007", "value": "4"}, {"groupId": "BG008", "value": "255"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "9"}, {"groupId": "BG003", "value": "11"}, {"groupId": "BG004", "value": "11"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "32"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "44"}, {"groupId": "BG001", "value": "45"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "23"}, {"groupId": "BG004", "value": "20"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "150"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "44"}, {"groupId": "BG003", "value": "37"}, {"groupId": "BG004", "value": "41"}, {"groupId": "BG005", "value": "6"}, {"groupId": "BG006", "value": "6"}, {"groupId": "BG007", "value": "6"}, {"groupId": "BG008", "value": "147"}]}]}]}, {"title": "Race/Ethnicity, Customized", "description": "Race", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "White", "measurements": [{"groupId": "BG000", "value": "35"}, {"groupId": "BG001", "value": "37"}, {"groupId": "BG002", "value": "63"}, {"groupId": "BG003", "value": "62"}, {"groupId": "BG004", "value": "66"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "263"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "11"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "7"}, {"groupId": "BG004", "value": "4"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "37"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "2"}, {"groupId": "BG004", "value": "2"}, {"groupId": "BG005", "value": "6"}, {"groupId": "BG006", "value": "6"}, {"groupId": "BG007", "value": "6"}, {"groupId": "BG008", "value": "24"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "5"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Percentage of Participants With Clinically Relevant Hypotension up to 6 Hours After the End of Study Drug Infusion", "description": "Percentage of participants with clinically relevant hypotension, defined by systolic blood pressure (SBP) \\< 90 mm Hg (confirmed by a repeated value \\< 90 mm Hg) or symptoms of hypotension, up to 6 hours after the end of study drug infusion", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of participants", "timeFrame": "From start of infusion up to 6 hours post end of infusion", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "clinically relevant hypotension", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.3", "lowerLimit": "2.32", "upperLimit": "19.98"}, {"groupId": "OG001", "value": "20.4", "lowerLimit": "10.24", "upperLimit": "34.34"}, {"groupId": "OG002", "value": "18.3", "lowerLimit": "10.13", "upperLimit": "29.27"}, {"groupId": "OG003", "value": "21.1", "lowerLimit": "12.33", "upperLimit": "32.44"}, {"groupId": "OG004", "value": "34.7", "lowerLimit": "23.88", "upperLimit": "46.86"}, {"groupId": "OG005", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG006", "value": "33.3", "lowerLimit": "4.33", "upperLimit": "77.72"}, {"groupId": "OG007", "value": "50.0", "lowerLimit": "11.81", "upperLimit": "88.19"}]}]}, {"title": "symptoms of hypotension", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.1", "lowerLimit": "0.05", "upperLimit": "11.07"}, {"groupId": "OG001", "value": "6.1", "lowerLimit": "1.28", "upperLimit": "16.87"}, {"groupId": "OG002", "value": "1.4", "lowerLimit": "0.04", "upperLimit": "7.60"}, {"groupId": "OG003", "value": "2.8", "lowerLimit": "0.34", "upperLimit": "9.81"}, {"groupId": "OG004", "value": "8.3", "lowerLimit": "3.12", "upperLimit": "17.26"}, {"groupId": "OG005", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG006", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG007", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}]}]}, {"title": "confirmed SBP < 90 mmHg", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.3", "lowerLimit": "1.31", "upperLimit": "17.20"}, {"groupId": "OG001", "value": "20.4", "lowerLimit": "10.24", "upperLimit": "34.34"}, {"groupId": "OG002", "value": "18.3", "lowerLimit": "10.13", "upperLimit": "29.27"}, {"groupId": "OG003", "value": "21.1", "lowerLimit": "12.33", "upperLimit": "32.44"}, {"groupId": "OG004", "value": "29.2", "lowerLimit": "19.05", "upperLimit": "41.07"}, {"groupId": "OG005", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG006", "value": "33.3", "lowerLimit": "4.33", "upperLimit": "77.72"}, {"groupId": "OG007", "value": "50.0", "lowerLimit": "11.81", "upperLimit": "88.19"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, clinically relevant hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "2.45", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.83", "ciUpperLimit": "14.53"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, clinically relevant hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.12", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.02", "ciUpperLimit": "0.28"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, symptoms of hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "2.94", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.31", "ciUpperLimit": "75.47"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, symptoms of hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.04", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.06", "ciUpperLimit": "0.15"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, confirmed SBP \\< 90 mmHg - relative risk", "paramType": "Relative risk from placebo", "paramValue": "3.27", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.01", "ciUpperLimit": "14.66"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.14", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.00", "ciUpperLimit": "0.29"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), clinically relevant hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "1.15", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.58", "ciUpperLimit": "2.43"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), clinically relevant hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.03", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.11", "ciUpperLimit": "0.16"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), symptoms of hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "2.00", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.18", "ciUpperLimit": "54.35"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), symptoms of hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.01", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.05", "ciUpperLimit": "0.09"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), confirmed SBP \\< 90 mmHg - relative risk", "paramType": "Relative risk from placebo", "paramValue": "1.15", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.58", "ciUpperLimit": "2.43"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.03", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.11", "ciUpperLimit": "0.16"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), clinically relevant hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "1.90", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.04", "ciUpperLimit": "3.59"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), clinically relevant hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.16", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.01", "ciUpperLimit": "0.31"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), symptoms of hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "5.92", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.91", "ciUpperLimit": "149.72"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), symptoms of hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.07", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.01", "ciUpperLimit": "0.16"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), confirmed SBP \\< 90 mmHg - relative risk", "paramType": "Relative risk from placebo", "paramValue": "1.59", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.87", "ciUpperLimit": "3.21"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.11", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.04", "ciUpperLimit": "0.25"}, {"groupIds": ["OG005", "OG006"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II-Japan (low dose), clinically relevant hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.33", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.17", "ciUpperLimit": "0.78"}, {"groupIds": ["OG005", "OG006"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II-Japan (low dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.33", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.17", "ciUpperLimit": "0.78"}, {"groupIds": ["OG005", "OG007"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II-Japan (high dose), clinically relevant hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.50", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.04", "ciUpperLimit": "0.88"}, {"groupIds": ["OG005", "OG007"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II-Japan (high dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.50", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.04", "ciUpperLimit": "0.88"}]}, {"type": "SECONDARY", "title": "Change in NT-proBNP From Baseline to Hour 24, 48, 72, 120 or Discharge (Whichever Comes First), and at Day 32", "description": "Assess the effect of BMS-986231 on NT-proBNP (N-terminal prohormone of brain natriuretic peptide)", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pmol/L", "timeFrame": "0, 24, 48, 72, 120 hour or discharge; Day 32", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "24 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "45"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-270.88", "spread": "400.320"}, {"groupId": "OG001", "value": "-364.46", "spread": "456.158"}, {"groupId": "OG002", "value": "-147.96", "spread": "452.239"}, {"groupId": "OG003", "value": "-340.74", "spread": "430.639"}, {"groupId": "OG004", "value": "-416.91", "spread": "503.825"}, {"groupId": "OG005", "value": "-129.70", "spread": "255.716"}, {"groupId": "OG006", "value": "-165.93", "spread": "185.910"}, {"groupId": "OG007", "value": "-397.60", "spread": "330.721"}]}]}, {"title": "48 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "43"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-405.06", "spread": "591.711"}, {"groupId": "OG001", "value": "-510.51", "spread": "592.734"}, {"groupId": "OG002", "value": "-210.87", "spread": "580.487"}, {"groupId": "OG003", "value": "-300.87", "spread": "725.268"}, {"groupId": "OG004", "value": "-472.32", "spread": "610.590"}, {"groupId": "OG005", "value": "-329.24", "spread": "646.985"}, {"groupId": "OG006", "value": "-251.73", "spread": "243.794"}, {"groupId": "OG007", "value": "-497.35", "spread": "725.286"}]}]}, {"title": "72 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-396.21", "spread": "675.761"}, {"groupId": "OG001", "value": "-373.86", "spread": "702.530"}, {"groupId": "OG002", "value": "-249.26", "spread": "655.999"}, {"groupId": "OG003", "value": "-118.86", "spread": "900.798"}, {"groupId": "OG004", "value": "-293.94", "spread": "685.681"}, {"groupId": "OG005", "value": "-433.08", "spread": "761.573"}, {"groupId": "OG006", "value": "9.89", "spread": "523.754"}, {"groupId": "OG007", "value": "-229.56", "spread": "809.850"}]}]}, {"title": "120 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-541.36", "spread": "773.006"}, {"groupId": "OG001", "value": "-409.53", "spread": "751.624"}, {"groupId": "OG002", "value": "-140.60", "spread": "1358.127"}, {"groupId": "OG003", "value": "-76.20", "spread": "993.110"}, {"groupId": "OG004", "value": "-390.21", "spread": "717.114"}, {"groupId": "OG005", "value": "-434.36", "spread": "659.528"}, {"groupId": "OG006", "value": "-379.06", "spread": "244.917"}, {"groupId": "OG007", "value": "-552.55", "spread": "824.009"}]}]}, {"title": "Day 32", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "42"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-202.07", "spread": "799.169"}, {"groupId": "OG001", "value": "-91.61", "spread": "2254.397"}, {"groupId": "OG002", "value": "-321.73", "spread": "600.297"}, {"groupId": "OG003", "value": "-361.73", "spread": "782.881"}, {"groupId": "OG004", "value": "-476.86", "spread": "716.072"}, {"groupId": "OG005", "value": "-556.69", "spread": "1288.342"}, {"groupId": "OG006", "value": "-343.64", "spread": "377.590"}, {"groupId": "OG007", "value": "-706.11", "spread": "1111.877"}]}]}]}, {"type": "SECONDARY", "title": "Change in Participant-reported Resting Dyspnea From Baseline Through Hour 72", "description": "Endpoint was measured by the area under the curve (AUC) of the 11-point Numerical Rating Scale (NRS) obtained at baseline, and Hours 6, 12, 24, 48, and 72.\n\nParticipants were asked to report their absolute current severity of dyspnea on an 11-point numerical rating scale (NRS; range 0 to 10).\n\nThe numerical rating scale (NRS) was used to assess the degree of dyspnea (breathlessness), measured using an 11-point scale provided by the Sponsor.\n\nA score of 0 represents \"I am not breathless at all\" and 10 represents \"I am the most breathless I can possibly imagine\".", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Scores on a scale", "timeFrame": "Hours 6, 12, 24, 48, and 72", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "6 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "44"}, {"groupId": "OG002", "value": "68"}, {"groupId": "OG003", "value": "66"}, {"groupId": "OG004", "value": "68"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.5", "spread": "1.84"}, {"groupId": "OG001", "value": "-1.5", "spread": "1.64"}, {"groupId": "OG002", "value": "-1.1", "spread": "1.90"}, {"groupId": "OG003", "value": "-1.7", "spread": "1.94"}, {"groupId": "OG004", "value": "-1.7", "spread": "2.13"}, {"groupId": "OG005", "value": "-0.3", "spread": "1.03"}, {"groupId": "OG006", "value": "0.0", "spread": "2.90"}, {"groupId": "OG007", "value": "-1.3", "spread": "3.44"}]}]}, {"title": "12 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "42"}, {"groupId": "OG001", "value": "42"}, {"groupId": "OG002", "value": "65"}, {"groupId": "OG003", "value": "64"}, {"groupId": "OG004", "value": "66"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.1", "spread": "2.38"}, {"groupId": "OG001", "value": "-2.2", "spread": "1.73"}, {"groupId": "OG002", "value": "-1.7", "spread": "2.75"}, {"groupId": "OG003", "value": "-2.4", "spread": "2.38"}, {"groupId": "OG004", "value": "-2.0", "spread": "2.49"}, {"groupId": "OG005", "value": "-1.0", "spread": "1.79"}, {"groupId": "OG006", "value": "-0.2", "spread": "3.37"}, {"groupId": "OG007", "value": "-1.4", "spread": "4.22"}]}]}, {"title": "24 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "44"}, {"groupId": "OG001", "value": "46"}, {"groupId": "OG002", "value": "67"}, {"groupId": "OG003", "value": "67"}, {"groupId": "OG004", "value": "70"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "2.50"}, {"groupId": "OG001", "value": "-2.1", "spread": "2.19"}, {"groupId": "OG002", "value": "-2.1", "spread": "2.82"}, {"groupId": "OG003", "value": "-2.9", "spread": "2.68"}, {"groupId": "OG004", "value": "-2.2", "spread": "2.42"}, {"groupId": "OG005", "value": "-0.8", "spread": "1.72"}, {"groupId": "OG006", "value": "-1.5", "spread": "3.02"}, {"groupId": "OG007", "value": "-1.2", "spread": "2.14"}]}]}, {"title": "48 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "42"}, {"groupId": "OG001", "value": "46"}, {"groupId": "OG002", "value": "66"}, {"groupId": "OG003", "value": "67"}, {"groupId": "OG004", "value": "68"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.8", "spread": "2.15"}, {"groupId": "OG001", "value": "-2.6", "spread": "2.51"}, {"groupId": "OG002", "value": "-2.8", "spread": "3.00"}, {"groupId": "OG003", "value": "-3.4", "spread": "2.44"}, {"groupId": "OG004", "value": "-2.8", "spread": "2.45"}, {"groupId": "OG005", "value": "-1.2", "spread": "1.47"}, {"groupId": "OG006", "value": "-0.8", "spread": "3.43"}, {"groupId": "OG007", "value": "-2.0", "spread": "1.67"}]}]}, {"title": "72 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "39"}, {"groupId": "OG002", "value": "63"}, {"groupId": "OG003", "value": "60"}, {"groupId": "OG004", "value": "68"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.9", "spread": "2.23"}, {"groupId": "OG001", "value": "-3.7", "spread": "2.22"}, {"groupId": "OG002", "value": "-3.2", "spread": "3.19"}, {"groupId": "OG003", "value": "-3.9", "spread": "2.28"}, {"groupId": "OG004", "value": "-3.2", "spread": "2.73"}, {"groupId": "OG005", "value": "-1.2", "spread": "2.14"}, {"groupId": "OG006", "value": "-1.2", "spread": "3.19"}, {"groupId": "OG007", "value": "-2.0", "spread": "2.00"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Symptomatic Hypotension up to 6 Hours After the End of Study Drug Infusion", "description": "The percentage of participants experiencing symptoms of hypotension up to 6 hours post-treatment was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of participants", "timeFrame": "From start of infusion up to 6 hours post end of infusion", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.1", "lowerLimit": "0.05", "upperLimit": "11.07"}, {"groupId": "OG001", "value": "6.1", "lowerLimit": "1.28", "upperLimit": "16.87"}, {"groupId": "OG002", "value": "1.4", "lowerLimit": "0.04", "upperLimit": "7.60"}, {"groupId": "OG003", "value": "2.8", "lowerLimit": "0.34", "upperLimit": "9.81"}, {"groupId": "OG004", "value": "8.3", "lowerLimit": "3.12", "upperLimit": "17.26"}, {"groupId": "OG005", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG006", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG007", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, symptoms of hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "2.94", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.31", "ciUpperLimit": "75.47"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, symptoms of hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.04", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.06", "ciUpperLimit": "0.15"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), symptoms of hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "2.00", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.18", "ciUpperLimit": "54.35"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), symptoms of hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.01", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.05", "ciUpperLimit": "0.09"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), symptoms of hypotension - relative risk", "paramType": "Relative risk from placebo", "paramValue": "5.92", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.91", "ciUpperLimit": "149.72"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), symptoms of hypotension - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.07", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.01", "ciUpperLimit": "0.16"}]}, {"type": "SECONDARY", "title": "Percentage of Participants With SBP < 90 mm Hg (Confirmed by a Repeated Value)", "description": "The percentage of participants experiencing SBP \\< 90 mm Hg (confirmed by a repeated value) up to 6 hours post-treatment was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of participants", "timeFrame": "From start of infusion up to 6 hours post end of infusion", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.3", "lowerLimit": "1.31", "upperLimit": "17.20"}, {"groupId": "OG001", "value": "20.4", "lowerLimit": "10.24", "upperLimit": "34.34"}, {"groupId": "OG002", "value": "18.3", "lowerLimit": "10.13", "upperLimit": "29.27"}, {"groupId": "OG003", "value": "21.1", "lowerLimit": "12.33", "upperLimit": "32.44"}, {"groupId": "OG004", "value": "29.2", "lowerLimit": "19.05", "upperLimit": "41.07"}, {"groupId": "OG005", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG006", "value": "33.3", "lowerLimit": "4.33", "upperLimit": "77.72"}, {"groupId": "OG007", "value": "50.0", "lowerLimit": "11.81", "upperLimit": "88.19"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, confirmed SBP \\< 90 mmHg - relative risk", "paramType": "Relative risk from placebo", "paramValue": "3.27", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.01", "ciUpperLimit": "14.66"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part I, confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.14", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.00", "ciUpperLimit": "0.29"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), confirmed SBP \\< 90 mmHg - relative risk", "paramType": "Relative risk from placebo", "paramValue": "1.15", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.58", "ciUpperLimit": "2.43"}, {"groupIds": ["OG002", "OG003"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (low dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.03", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.11", "ciUpperLimit": "0.16"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), confirmed SBP \\< 90 mmHg - relative risk", "paramType": "Relative risk from placebo", "paramValue": "1.59", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.87", "ciUpperLimit": "3.21"}, {"groupIds": ["OG002", "OG004"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II (high dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.11", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.04", "ciUpperLimit": "0.25"}, {"groupIds": ["OG005", "OG006"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II-Japan (low dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.33", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.17", "ciUpperLimit": "0.78"}, {"groupIds": ["OG005", "OG007"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Part II-Japan (high dose), confirmed SBP \\< 90 mmHg - relative difference", "paramType": "Relative difference from placebo", "paramValue": "0.50", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.04", "ciUpperLimit": "0.88"}]}, {"type": "SECONDARY", "title": "Number of Participants With a Serious Adverse Events (SAE) Assessed up to Day 32", "description": "Number of participants who experienced an in-study SAE.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0 Included serious adverse events with onset time from the start of study treatment, up to and including 32 days after the start of study treatment.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "32 days", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "14"}, {"groupId": "OG002", "value": "23"}, {"groupId": "OG003", "value": "15"}, {"groupId": "OG004", "value": "15"}, {"groupId": "OG005", "value": "1"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Who Discontinued Due to Hypotension", "description": "Number of participants who discontinued study treatment due to hypotension.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nIncluded nonserious adverse events with onset time from the start of study treatment, up to and including 120 hours after the start of study treatment and serious adverse events with onset time from the start of study treatment, up to and including 32 days after the start of study treatment.\n\nHypotension defined as systolic blood pressure (SBP) \\< 90 mmHg.", "populationDescription": "All treated participants\n\nNote: Discontinuation due to hypotension occurred per protocol-mandated lowering of blood pressure to \\< 90 mmHg.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "up to 120 hours (for AEs); up to 32 days (for SAEs)", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "13"}, {"groupId": "OG004", "value": "16"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "3"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Who Discontinued, Experienced a Down-titration or Dose Interruption Due to Decreased Blood Pressure", "description": "Number of participants who discontinued study treatment, experienced a down-titration (dose reduction) or dose interruption due to decreased blood pressure/hypotension are reported below.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nIncluded nonserious adverse events with onset time from the start of study treatment, up to and including 120 hours after the start of study treatment and serious adverse events with onset time from the start of study treatment, up to and including 32 days after the start of study treatment.\n\nIf the participant experienced systolic blood pressure (SBP) \\< 95 mm Hg, without symptoms related to hypotension, the measurement was repeated within 15 minutes. If the SBP remained \\< 95 mm Hg, the dose reduction occurred.", "populationDescription": "All treated participants\n\nNote: Discontinuation due to decreased blood pressure occurred per protocol-mandated lowering of blood pressure to \\< 95 mmHg.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "up to 120 hours (for AEs); up to 32 days (for SAEs)", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "discontinuation", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "8"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "13"}, {"groupId": "OG004", "value": "15"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "3"}]}]}, {"title": "down-titration", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "9"}, {"groupId": "OG003", "value": "10"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "3"}]}]}, {"title": "interruption", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "4"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "12"}, {"groupId": "OG004", "value": "13"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With an Adverse Event (AE) Assessed up to 120 Hours", "description": "Number of participants who experienced an in-study AE.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nIncluded nonserious adverse events with onset time from the start of study treatment, up to and including 120 hours after the start of study treatment.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "up to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "31"}, {"groupId": "OG001", "value": "39"}, {"groupId": "OG002", "value": "48"}, {"groupId": "OG003", "value": "48"}, {"groupId": "OG004", "value": "55"}, {"groupId": "OG005", "value": "2"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Who Died (All- Cause and Cardiovascular-related) Through Day 182", "description": "Number of participants who died (all- cause and CV related) through Day 182.\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0\n\nCV=Cardiovascular", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Participants", "timeFrame": "through 182 days", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "All-cause", "categories": [{"measurements": [{"groupId": "OG000", "value": "3", "lowerLimit": "1.31", "upperLimit": "17.20"}, {"groupId": "OG001", "value": "3", "lowerLimit": "1.28", "upperLimit": "16.87"}, {"groupId": "OG002", "value": "11", "lowerLimit": "8.00", "upperLimit": "26.03"}, {"groupId": "OG003", "value": "12", "lowerLimit": "9.05", "upperLimit": "27.66"}, {"groupId": "OG004", "value": "9", "lowerLimit": "5.88", "upperLimit": "22.41"}, {"groupId": "OG005", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG006", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG007", "value": "1", "lowerLimit": "0.42", "upperLimit": "64.12"}]}]}, {"title": "CV-related", "categories": [{"measurements": [{"groupId": "OG000", "value": "3", "lowerLimit": "1.31", "upperLimit": "17.20"}, {"groupId": "OG001", "value": "2", "lowerLimit": "0.50", "upperLimit": "13.98"}, {"groupId": "OG002", "value": "9", "lowerLimit": "5.96", "upperLimit": "22.70"}, {"groupId": "OG003", "value": "10", "lowerLimit": "6.97", "upperLimit": "24.38"}, {"groupId": "OG004", "value": "4", "lowerLimit": "1.53", "upperLimit": "13.62"}, {"groupId": "OG005", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG006", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}, {"groupId": "OG007", "value": "0", "lowerLimit": "0.00", "upperLimit": "45.93"}]}]}]}, {"type": "SECONDARY", "title": "Change in Troponin T From Baseline to Hour 24, 48, and 72", "description": "Baseline = Last non-missing result with a collection date-time less than or on the date-time of the start of infusion of study drug", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ng/L", "timeFrame": "from baseline to Hour 24, 48, and 72", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "24 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "41"}, {"groupId": "OG001", "value": "44"}, {"groupId": "OG002", "value": "69"}, {"groupId": "OG003", "value": "66"}, {"groupId": "OG004", "value": "68"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.11", "spread": "27.303"}, {"groupId": "OG001", "value": "-1.31", "spread": "12.278"}, {"groupId": "OG002", "value": "-1.80", "spread": "11.266"}, {"groupId": "OG003", "value": "-3.45", "spread": "20.030"}, {"groupId": "OG004", "value": "-8.09", "spread": "37.864"}, {"groupId": "OG005", "value": "-4.67", "spread": "3.983"}, {"groupId": "OG006", "value": "1.33", "spread": "5.750"}, {"groupId": "OG007", "value": "-7.67", "spread": "16.669"}]}]}, {"title": "48 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "41"}, {"groupId": "OG001", "value": "44"}, {"groupId": "OG002", "value": "64"}, {"groupId": "OG003", "value": "63"}, {"groupId": "OG004", "value": "68"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.93", "spread": "22.714"}, {"groupId": "OG001", "value": "14.56", "spread": "81.979"}, {"groupId": "OG002", "value": "-2.88", "spread": "16.424"}, {"groupId": "OG003", "value": "8.08", "spread": "71.672"}, {"groupId": "OG004", "value": "-11.15", "spread": "45.495"}, {"groupId": "OG005", "value": "-10.67", "spread": "10.633"}, {"groupId": "OG006", "value": "49.50", "spread": "118.417"}, {"groupId": "OG007", "value": "-8.40", "spread": "25.501"}]}]}, {"title": "72 hour", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "63"}, {"groupId": "OG003", "value": "57"}, {"groupId": "OG004", "value": "65"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6.07", "spread": "30.033"}, {"groupId": "OG001", "value": "6.76", "spread": "66.673"}, {"groupId": "OG002", "value": "-1.44", "spread": "16.472"}, {"groupId": "OG003", "value": "5.00", "spread": "65.766"}, {"groupId": "OG004", "value": "-13.05", "spread": "68.276"}, {"groupId": "OG005", "value": "-10.50", "spread": "12.145"}, {"groupId": "OG006", "value": "248.00", "spread": "433.581"}, {"groupId": "OG007", "value": "-15.00", "spread": "25.169"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Marked Laboratory Abnormality Assessed to 120 Hours - Hematology", "description": "Number of participants who experienced an in-study Hematology marked laboratory abnormality (reported in \\> 5% of total participants).\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "high leukocyte counts", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "3"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low hemoglobin values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "4"}, {"groupId": "OG005", "value": "1"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low platelet values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "67"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "7"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low neutrophils values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "46"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "67"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low leukocyte counts", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low hematocrit values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "3"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low erythrocytes values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "3"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Marked Laboratory Abnormality Assessed to 120 Hours - Chemistry", "description": "Number of participants who experienced an in-study Chemistry marked laboratory abnormality (reported in \\> 5% of total participants).\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "high blood urea nitrogen values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "16"}, {"groupId": "OG002", "value": "23"}, {"groupId": "OG003", "value": "23"}, {"groupId": "OG004", "value": "18"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "2"}]}]}, {"title": "high urate values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "15"}, {"groupId": "OG002", "value": "10"}, {"groupId": "OG003", "value": "20"}, {"groupId": "OG004", "value": "8"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "1"}]}]}, {"title": "high potassium values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "7"}, {"groupId": "OG004", "value": "2"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high alanine aminotransferase (ALT) values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "2"}, {"groupId": "OG004", "value": "2"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high alkaline phosphatase values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low protein values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "8"}, {"groupId": "OG004", "value": "4"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high asparate aminotransferase values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "2"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high bilirubin values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high bicarbonate values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low chloride counts", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high creatine kinase values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high protein values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "2"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high sodium values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low bicarbonate values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low sodium values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "2"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low albumin values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "69"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "2"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "low calcium values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "2"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "2"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Marked Laboratory Abnormality Assessed to 120 Hours - Urinalysis", "description": "Number of participants who experienced an in-study Urinalysis marked laboratory abnormality (reported in \\> 5% of total participants).\n\nMedical Dictionary for Regulatory Activities (MedDRA) version: 22.0", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "high protein values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "48"}, {"groupId": "OG002", "value": "61"}, {"groupId": "OG003", "value": "64"}, {"groupId": "OG004", "value": "69"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "5"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "16"}, {"groupId": "OG003", "value": "13"}, {"groupId": "OG004", "value": "17"}, {"groupId": "OG005", "value": "2"}, {"groupId": "OG006", "value": "2"}, {"groupId": "OG007", "value": "2"}]}]}, {"title": "high erythrocyte values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "28"}, {"groupId": "OG001", "value": "38"}, {"groupId": "OG002", "value": "47"}, {"groupId": "OG003", "value": "47"}, {"groupId": "OG004", "value": "50"}, {"groupId": "OG005", "value": "5"}, {"groupId": "OG006", "value": "5"}, {"groupId": "OG007", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "3"}, {"groupId": "OG004", "value": "2"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}, {"title": "high leukocytes values", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "47"}, {"groupId": "OG003", "value": "47"}, {"groupId": "OG004", "value": "50"}, {"groupId": "OG005", "value": "5"}, {"groupId": "OG006", "value": "5"}, {"groupId": "OG007", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "2"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "0"}, {"groupId": "OG006", "value": "0"}, {"groupId": "OG007", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Change in Vital Signs From Baseline to 120 Hours - Blood Pressure", "description": "The change in baseline for vital signs was reported for each arm.", "populationDescription": "All treated participants with a 120-hour evaluation", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "26"}, {"groupId": "OG002", "value": "50"}, {"groupId": "OG003", "value": "48"}, {"groupId": "OG004", "value": "44"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "systolic blood pressure, mmHg", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.8", "spread": "16.60"}, {"groupId": "OG001", "value": "0.0", "spread": "17.75"}, {"groupId": "OG002", "value": "-4.3", "spread": "15.23"}, {"groupId": "OG003", "value": "-7.9", "spread": "15.60"}, {"groupId": "OG004", "value": "-8.8", "spread": "14.01"}, {"groupId": "OG005", "value": "-10.3", "spread": "15.60"}, {"groupId": "OG006", "value": "-17.5", "spread": "9.14"}, {"groupId": "OG007", "value": "-6.2", "spread": "16.44"}]}]}, {"title": "diastolic blood pressure, mmHg", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.0", "spread": "12.67"}, {"groupId": "OG001", "value": "-1.9", "spread": "13.53"}, {"groupId": "OG002", "value": "-4.4", "spread": "12.99"}, {"groupId": "OG003", "value": "-3.4", "spread": "14.37"}, {"groupId": "OG004", "value": "-1.6", "spread": "10.83"}, {"groupId": "OG005", "value": "1.7", "spread": "16.24"}, {"groupId": "OG006", "value": "-15.7", "spread": "19.08"}, {"groupId": "OG007", "value": "-9.3", "spread": "14.45"}]}]}]}, {"type": "SECONDARY", "title": "Change in Vital Signs From Baseline to 120 Hours - Heart Rate", "description": "The change in baseline for vital signs was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "beats/min", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1.8", "spread": "15.53"}, {"groupId": "OG001", "value": "-9.1", "spread": "17.13"}, {"groupId": "OG002", "value": "-8.3", "spread": "15.55"}, {"groupId": "OG003", "value": "-4.6", "spread": "15.40"}, {"groupId": "OG004", "value": "-6.3", "spread": "15.60"}, {"groupId": "OG005", "value": "-6.7", "spread": "21.88"}, {"groupId": "OG006", "value": "-3.0", "spread": "13.31"}, {"groupId": "OG007", "value": "3.8", "spread": "11.55"}]}]}]}, {"type": "SECONDARY", "title": "Change in Vital Signs From Baseline to 120 Hours - Respiratory Rate", "description": "The change in baseline for vital signs was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "breaths/min", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.6", "spread": "3.93"}, {"groupId": "OG001", "value": "-3.0", "spread": "4.82"}, {"groupId": "OG002", "value": "-2.9", "spread": "3.80"}, {"groupId": "OG003", "value": "-2.6", "spread": "4.33"}, {"groupId": "OG004", "value": "-1.8", "spread": "3.96"}, {"groupId": "OG005", "value": "-2.3", "spread": "2.88"}, {"groupId": "OG006", "value": "0.0", "spread": "9.98"}, {"groupId": "OG007", "value": "-1.4", "spread": "3.58"}]}]}]}, {"type": "SECONDARY", "title": "Change in Vital Signs From Baseline to 120 Hours - Temperature", "description": "The change in baseline for vital signs was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "degrees C", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.643"}, {"groupId": "OG001", "value": "0.09", "spread": "0.649"}, {"groupId": "OG002", "value": "0.04", "spread": "0.427"}, {"groupId": "OG003", "value": "0.00", "spread": "0.342"}, {"groupId": "OG004", "value": "-0.05", "spread": "0.481"}, {"groupId": "OG005", "value": "-0.47", "spread": "0.650"}, {"groupId": "OG006", "value": "-0.27", "spread": "0.535"}, {"groupId": "OG007", "value": "0.44", "spread": "0.541"}]}]}]}, {"type": "SECONDARY", "title": "Change in Electrocardiograms (ECGs) From Baseline to 120 Hours - Mean Heart Rate", "description": "The change in baseline for ECGs was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "beats/min", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "5"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-5.3", "spread": "9.36"}, {"groupId": "OG001", "value": "-6.8", "spread": "21.31"}, {"groupId": "OG002", "value": "-7.1", "spread": "17.46"}, {"groupId": "OG003", "value": "-5.1", "spread": "18.64"}, {"groupId": "OG004", "value": "-6.1", "spread": "17.33"}, {"groupId": "OG005", "value": "2.0", "spread": "10.72"}, {"groupId": "OG006", "value": "-13.0", "spread": "12.62"}, {"groupId": "OG007", "value": "-5.2", "spread": "14.85"}]}]}]}, {"type": "SECONDARY", "title": "Change in Electrocardiograms (ECGs) From Baseline to 120 Hours - PR, QT, QTcF Intervals and QRS Duration", "description": "The change in baseline for ECGs was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "msec", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"title": "PR Interval, Aggregate, msec", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "12"}, {"groupId": "OG002", "value": "19"}, {"groupId": "OG003", "value": "26"}, {"groupId": "OG004", "value": "23"}, {"groupId": "OG005", "value": "4"}, {"groupId": "OG006", "value": "5"}, {"groupId": "OG007", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-17.4", "spread": "66.31"}, {"groupId": "OG001", "value": "-2.3", "spread": "32.11"}, {"groupId": "OG002", "value": "-0.1", "spread": "23.49"}, {"groupId": "OG003", "value": "10.9", "spread": "22.02"}, {"groupId": "OG004", "value": "2.0", "spread": "25.41"}, {"groupId": "OG005", "value": "-1.5", "spread": "16.50"}, {"groupId": "OG006", "value": "10.4", "spread": "26.32"}, {"groupId": "OG007", "value": "6.0", "spread": "30.10"}]}]}, {"title": "QRS Duration, Aggregate, msec", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "21"}, {"groupId": "OG002", "value": "43"}, {"groupId": "OG003", "value": "43"}, {"groupId": "OG004", "value": "44"}, {"groupId": "OG005", "value": "5"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.1", "spread": "22.19"}, {"groupId": "OG001", "value": "-0.1", "spread": "12.46"}, {"groupId": "OG002", "value": "1.6", "spread": "20.29"}, {"groupId": "OG003", "value": "-1.6", "spread": "13.22"}, {"groupId": "OG004", "value": "2.7", "spread": "16.77"}, {"groupId": "OG005", "value": "-3.0", "spread": "4.80"}, {"groupId": "OG006", "value": "-2.5", "spread": "7.20"}, {"groupId": "OG007", "value": "3.0", "spread": "4.38"}]}]}, {"title": "QT Interval, Aggregate, msec", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "42"}, {"groupId": "OG004", "value": "44"}, {"groupId": "OG005", "value": "5"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-10.6", "spread": "49.20"}, {"groupId": "OG001", "value": "7.2", "spread": "48.25"}, {"groupId": "OG002", "value": "8.7", "spread": "53.17"}, {"groupId": "OG003", "value": "5.8", "spread": "42.19"}, {"groupId": "OG004", "value": "-0.3", "spread": "45.39"}, {"groupId": "OG005", "value": "-30.0", "spread": "28.17"}, {"groupId": "OG006", "value": "5.7", "spread": "24.41"}, {"groupId": "OG007", "value": "16.5", "spread": "50.22"}]}]}, {"title": "QTcF Interval, Aggregate, msec", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "21"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "43"}, {"groupId": "OG004", "value": "44"}, {"groupId": "OG005", "value": "5"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-27.5", "spread": "41.79"}, {"groupId": "OG001", "value": "-13.9", "spread": "41.56"}, {"groupId": "OG002", "value": "-4.0", "spread": "51.04"}, {"groupId": "OG003", "value": "-4.0", "spread": "33.59"}, {"groupId": "OG004", "value": "-10.3", "spread": "37.63"}, {"groupId": "OG005", "value": "-24.8", "spread": "20.00"}, {"groupId": "OG006", "value": "-8.8", "spread": "22.35"}, {"groupId": "OG007", "value": "3.2", "spread": "22.93"}]}]}]}, {"type": "SECONDARY", "title": "Change in Physical Measurements From Baseline to 120 Hours", "description": "The change in baseline for physical measurements was reported for each arm.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "kg", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}, {"groupId": "OG005", "value": "6"}, {"groupId": "OG006", "value": "6"}, {"groupId": "OG007", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "0383"}, {"groupId": "OG001", "value": "0.10", "spread": "0.285"}, {"groupId": "OG002", "value": "-2.87", "spread": "4.447"}, {"groupId": "OG003", "value": "-2.96", "spread": "4.231"}, {"groupId": "OG004", "value": "-1.83", "spread": "5.295"}, {"groupId": "OG005", "value": "-3.58", "spread": "2.182"}, {"groupId": "OG006", "value": "-3.97", "spread": "2.160"}, {"groupId": "OG007", "value": "-6.08", "spread": "4.009"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - x10^9 Cells/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "populationDescription": "All treated participants with a 120-hour evaluation", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "x10^9 cells/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "36"}, {"groupId": "OG004", "value": "39"}]}], "classes": [{"title": "leukocyte, x10^9 c/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "36"}, {"groupId": "OG004", "value": "39"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "3.078"}, {"groupId": "OG001", "value": "-1.38", "spread": "1.892"}, {"groupId": "OG002", "value": "-0.20", "spread": "4.370"}, {"groupId": "OG003", "value": "0.20", "spread": "2.549"}, {"groupId": "OG004", "value": "-0.09", "spread": "1.980"}]}]}, {"title": "platelet, x10^9 c/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "22"}, {"groupId": "OG002", "value": "38"}, {"groupId": "OG003", "value": "34"}, {"groupId": "OG004", "value": "38"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.63", "spread": "31.679"}, {"groupId": "OG001", "value": "-5.77", "spread": "34.666"}, {"groupId": "OG002", "value": "1.84", "spread": "40.808"}, {"groupId": "OG003", "value": "3.26", "spread": "37.888"}, {"groupId": "OG004", "value": "1.26", "spread": "31.135"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - g/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "populationDescription": "All treated participants with a 120-hour evaluation", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "g/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "46"}, {"groupId": "OG003", "value": "42"}, {"groupId": "OG004", "value": "43"}]}], "classes": [{"title": "hemoglobin, g/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "41"}, {"groupId": "OG003", "value": "36"}, {"groupId": "OG004", "value": "39"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.67", "spread": "11.851"}, {"groupId": "OG001", "value": "-0.70", "spread": "8.573"}, {"groupId": "OG002", "value": "1.20", "spread": "11.487"}, {"groupId": "OG003", "value": "0.94", "spread": "11.684"}, {"groupId": "OG004", "value": "1.38", "spread": "9.161"}]}]}, {"title": "protein, g/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "22"}, {"groupId": "OG002", "value": "46"}, {"groupId": "OG003", "value": "42"}, {"groupId": "OG004", "value": "43"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.10", "spread": "6.172"}, {"groupId": "OG001", "value": "2.77", "spread": "5.839"}, {"groupId": "OG002", "value": "0.57", "spread": "8.178"}, {"groupId": "OG003", "value": "0.38", "spread": "6.048"}, {"groupId": "OG004", "value": "-0.05", "spread": "5.367"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - mmol/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmol/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}]}], "classes": [{"title": "blood urea nitrogen, mmol/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "48"}, {"groupId": "OG003", "value": "45"}, {"groupId": "OG004", "value": "46"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.01", "spread": "5.474"}, {"groupId": "OG001", "value": "0.32", "spread": "3.164"}, {"groupId": "OG002", "value": "1.96", "spread": "3.920"}, {"groupId": "OG003", "value": "2.15", "spread": "5.016"}, {"groupId": "OG004", "value": "1.24", "spread": "3.655"}]}]}, {"title": "urate, mmol/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "22"}, {"groupId": "OG002", "value": "46"}, {"groupId": "OG003", "value": "43"}, {"groupId": "OG004", "value": "42"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.154"}, {"groupId": "OG001", "value": "0.01", "spread": "0.108"}, {"groupId": "OG002", "value": "-0.01", "spread": "0.126"}, {"groupId": "OG003", "value": "0.04", "spread": "0.147"}, {"groupId": "OG004", "value": "-0.03", "spread": "0.111"}]}]}, {"title": "potassium, mmol/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "49"}, {"groupId": "OG003", "value": "46"}, {"groupId": "OG004", "value": "46"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.19", "spread": "0.697"}, {"groupId": "OG001", "value": "0.28", "spread": "0.513"}, {"groupId": "OG002", "value": "0.21", "spread": "0.692"}, {"groupId": "OG003", "value": "0.13", "spread": "0.558"}, {"groupId": "OG004", "value": "0.15", "spread": "0.651"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - U/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "U/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}]}], "classes": [{"title": "alanine aminotransferase (ALT), U/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "22"}, {"groupId": "OG002", "value": "46"}, {"groupId": "OG003", "value": "42"}, {"groupId": "OG004", "value": "43"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "148.13", "spread": "837.833"}, {"groupId": "OG001", "value": "-2.73", "spread": "11.089"}, {"groupId": "OG002", "value": "-3.22", "spread": "102.038"}, {"groupId": "OG003", "value": "30.36", "spread": "189.310"}, {"groupId": "OG004", "value": "-13.07", "spread": "76.357"}]}]}, {"title": "alkaline phosphatase, U/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "48"}, {"groupId": "OG003", "value": "44"}, {"groupId": "OG004", "value": "45"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.00", "spread": "28.018"}, {"groupId": "OG001", "value": "1.65", "spread": "11.052"}, {"groupId": "OG002", "value": "-1.31", "spread": "25.186"}, {"groupId": "OG003", "value": "5.43", "spread": "26.007"}, {"groupId": "OG004", "value": "-0.49", "spread": "21.474"}]}]}, {"title": "asparate aminotransferase, U/L", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "22"}, {"groupId": "OG002", "value": "46"}, {"groupId": "OG003", "value": "43"}, {"groupId": "OG004", "value": "43"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "214.77", "spread": "1204.410"}, {"groupId": "OG001", "value": "-2.77", "spread": "10.277"}, {"groupId": "OG002", "value": "-11.15", "spread": "127.903"}, {"groupId": "OG003", "value": "10.81", "spread": "65.009"}, {"groupId": "OG004", "value": "-10.00", "spread": "52.075"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - mg/dL", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "NA", "spread": "NA", "comment": "120 hour data not collected"}, {"groupId": "OG001", "value": "NA", "spread": "NA", "comment": "120 hour data not collected"}, {"groupId": "OG002", "value": "NA", "spread": "NA", "comment": "120 hour data not collected"}, {"groupId": "OG003", "value": "NA", "spread": "NA", "comment": "120 hour data not collected"}, {"groupId": "OG004", "value": "NA", "spread": "NA", "comment": "120 hour data not collected"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Main Study Cohorts Only - x10^12 c/L", "description": "The change in baseline for laboratory assessments was reported for each arm of the Main study cohorts only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "x10^12 c/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)"}, {"id": "OG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours"}, {"id": "OG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours"}, {"id": "OG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "48"}, {"groupId": "OG001", "value": "49"}, {"groupId": "OG002", "value": "71"}, {"groupId": "OG003", "value": "71"}, {"groupId": "OG004", "value": "72"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.02", "spread": "0.394"}, {"groupId": "OG001", "value": "0.02", "spread": "0.305"}, {"groupId": "OG002", "value": "0.04", "spread": "0.409"}, {"groupId": "OG003", "value": "0.04", "spread": "0.481"}, {"groupId": "OG004", "value": "0.09", "spread": "0.337"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Protein (Nmol/L)", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "nmol/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG001", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG002", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "79.38", "spread": "192.568"}, {"groupId": "OG001", "value": "74.13", "spread": "110.919"}, {"groupId": "OG002", "value": "131.64", "spread": "407.611"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Creatinine (\u00b5mol/L)", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "\u00b5mol/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG001", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG002", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4.33", "spread": "17.728"}, {"groupId": "OG001", "value": "-1.50", "spread": "6.775"}, {"groupId": "OG002", "value": "12.40", "spread": "23.891"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Cystatin (mg/L)", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/L", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG001", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG002", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.18", "spread": "0.268"}, {"groupId": "OG001", "value": "0.17", "spread": "0.150"}, {"groupId": "OG002", "value": "0.25", "spread": "0.077"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Percentage Fractional Potassium Excretion", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Fractional Potassium Excretion percent", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG001", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG002", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4.88", "spread": "8.009"}, {"groupId": "OG001", "value": "-1.22", "spread": "4.926"}, {"groupId": "OG002", "value": "-12.34", "spread": "13.316"}]}]}]}, {"type": "SECONDARY", "title": "Change in Laboratory Assessments From Baseline to 120 Hours, Japan Cohort Only - Percentage Fractional Sodium Excretion", "description": "The change in baseline for laboratory assessments was reported for each arm of the Japan cohort only.", "populationDescription": "All treated participants", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Fractional Sodium Excretion percent", "timeFrame": "to 120 hours", "groups": [{"id": "OG000", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG001", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants"}, {"id": "OG002", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.02", "spread": "2.076"}, {"groupId": "OG001", "value": "-2.62", "spread": "4.538"}, {"groupId": "OG002", "value": "-5.50", "spread": "7.984"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Includes non-serious adverse events with onset time from the start of study treatment, up to and including 120 hours after the start of study treatment and serious adverse events with onset time from the start of study treatment, up to and including 32 days after the start of study treatment. Mortality data reported through 182 days post-treatment", "eventGroups": [{"id": "EG000", "title": "Placebo - Part I", "description": "Escalating dose of placebo (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)", "deathsNumAffected": 3, "deathsNumAtRisk": 48, "seriousNumAffected": 11, "seriousNumAtRisk": 48, "otherNumAffected": 18, "otherNumAtRisk": 48}, {"id": "EG001", "title": "BMS-986231 - Part I", "description": "Escalating dose of BMS-986231 (3 \u00b5g/kg/min for 4 hours, then 6 \u00b5g/kg/min for another 4 hours, then 12 \u00b5g/kg/min for the remaining 40 hours)", "deathsNumAffected": 3, "deathsNumAtRisk": 49, "seriousNumAffected": 14, "seriousNumAtRisk": 49, "otherNumAffected": 40, "otherNumAtRisk": 49}, {"id": "EG002", "title": "Placebo - Part II", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours", "deathsNumAffected": 11, "deathsNumAtRisk": 71, "seriousNumAffected": 23, "seriousNumAtRisk": 71, "otherNumAffected": 47, "otherNumAtRisk": 71}, {"id": "EG003", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours", "deathsNumAffected": 12, "deathsNumAtRisk": 71, "seriousNumAffected": 15, "seriousNumAtRisk": 71, "otherNumAffected": 43, "otherNumAtRisk": 71}, {"id": "EG004", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours", "deathsNumAffected": 9, "deathsNumAtRisk": 72, "seriousNumAffected": 15, "seriousNumAtRisk": 72, "otherNumAffected": 54, "otherNumAtRisk": 72}, {"id": "EG005", "title": "Placebo - Part II (Japan Cohort)", "description": "Matching placebo dose of 6 \u00b5g/kg/min or 12 \u00b5g/kg/min for 48 hours for Japanese participants", "deathsNumAffected": 0, "deathsNumAtRisk": 6, "seriousNumAffected": 1, "seriousNumAtRisk": 6, "otherNumAffected": 2, "otherNumAtRisk": 6}, {"id": "EG006", "title": "BMS-986231 6 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 6 \u00b5g/kg/min for 48 hours for Japanese participants", "deathsNumAffected": 0, "deathsNumAtRisk": 6, "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 6, "otherNumAtRisk": 6}, {"id": "EG007", "title": "BMS-986231 12 \u00b5g/kg/Min - Part II (Japan Cohort)", "description": "BMS-986231 dose of 12 \u00b5g/kg/min for 48 hours for Japanese participants", "deathsNumAffected": 1, "deathsNumAtRisk": 6, "seriousNumAffected": 1, "seriousNumAtRisk": 6, "otherNumAffected": 6, "otherNumAtRisk": 6}], "seriousEvents": [{"term": "CARDIAC FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 8, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 7, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ACUTE MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CARDIAC FAILURE CONGESTIVE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CARDIOGENIC SHOCK", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CARDIORENAL SYNDROME", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "MYOCARDIAL INFARCTION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ATRIOVENTRICULAR BLOCK COMPLETE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CARDIAC FAILURE ACUTE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CORONARY ARTERY STENOSIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ANGINA PECTORIS", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ATRIOVENTRICULAR BLOCK", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CARDIAC ARREST", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "PERICARDIAL EFFUSION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "VENTRICULAR FIBRILLATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CARDIAC FAILURE CHRONIC", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CORONARY ARTERY DISEASE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "SINUS BRADYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "SUPRAVENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "VENTRICULAR ARRHYTHMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "VENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ACINETOBACTER BACTERAEMIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "PNEUMONIA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "BRONCHITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CELLULITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "SEPTIC SHOCK", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "STAPHYLOCOCCAL SEPSIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ENDOCARDITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ERYSIPELAS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CONFUSIONAL STATE", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "DELIRIUM", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ORGANIC BRAIN SYNDROME", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "HYPERCAPNIA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "SLEEP APNOEA SYNDROME", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ACUTE PULMONARY OEDEMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ASTHMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "DYSPNOEA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "PULMONARY OEDEMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "HYPERNATRAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "FLUID OVERLOAD", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ALTERED STATE OF CONSCIOUSNESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ACUTE KIDNEY INJURY", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "BLADDER MASS", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "END STAGE RENAL DISEASE", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "RENAL FAILURE", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ELECTROCARDIOGRAM QRS COMPLEX PROLONGED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ANGIOPATHY", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "HYPOTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 6}]}, {"term": "DEEP VEIN THROMBOSIS", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ILIAC ARTERY OCCLUSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "PERIPHERAL ARTERY OCCLUSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "BLADDER CANCER", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "SYSTEMIC INFLAMMATORY RESPONSE SYNDROME", "organSystem": "General disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "HEPATIC CONGESTION", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "WRIST FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "MYOCARDIAL ISCHAEMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}], "otherEvents": [{"term": "HYPOTENSION", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 14, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 15, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 20, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 31, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 3, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 4, "numAtRisk": 6}]}, {"term": "CARDIAC FAILURE", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 8, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 7, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "VENTRICULAR TACHYCARDIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 6}]}, {"term": "DIZZINESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "HYPERURICAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "HYPOKALAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 8, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 8, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 6}]}, {"term": "INSOMNIA", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 6}]}, {"term": "ACUTE KIDNEY INJURY", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "BLOOD CREATININE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "RENAL IMPAIRMENT", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "TRANSIENT ISCHAEMIC ATTACK", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 6}]}, {"term": "CONSTIPATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 6}]}, {"term": "DIARRHOEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "URINARY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 6}]}, {"term": "HYPOGLYCAEMIA", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "ATRIAL FIBRILLATION", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "MYOCARDIAL ISCHAEMIA", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "VITREOUS DETACHMENT", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "CHOLECYSTITIS", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "MUSCLE SPASMS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}, {"term": "RASH PRURITIC", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA version 22.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 48}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 49}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 72}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 6}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "LTE60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Bristol-Myers Squibb Study Director", "organization": "Bristol-Myers Squibb", "email": "Clinical.Trials@bms.com", "phone": "Please email:"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2017-06-21", "uploadDate": "2020-06-22T16:01", "filename": "SAP_001.pdf", "size": 2977739}, {"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2018-04-09", "uploadDate": "2020-11-09T15:45", "filename": "Prot_002.pdf", "size": 5682535}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M27583", "name": "Systolic Murmurs", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}}, "hasResults": true}